Brind.
  1. Soligenix, Inc. collaborated with John A. Burns School of Medicine on vaccine development relevant for virus-endemic countries in Africa.
  2. Vaccine trials are being conducted in Africa, alongside WHO estimates of the disease burden.

Texas Tech University led the development of the SchistoShield vaccine for schistosomiasis, conducting trials in African locations.

1 report, 1 independent Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Texas Tech University led the development of the SchistoShield vaccine for schistosomiasis, conducting trials in African locations.

Who's involved

What this event is mainly about
AfricaWorld Health Organization

Keep exploring

Part of

Vaccine trials are being conducted in Africa, alongside WHO estimates of the disease burden. All 1 developments

Within Soligenix, Inc. collaborated with John A. Burns School of Medicine on vaccine development relevant for virus-endemic countries in Africa.

The entities involved

Coverage

Newest first; wire copies grouped